The growth of the vaccine technologies market is driven by rise in prevalence of infectious diseases, growing trend towards preventive healthcare, and government immunization programs and initiatives.

Despite decades of efforts, tuberculosis remains a global health crisis, claiming over 1.3 million lives annually.

A landmark review in Molecular Biomedicine outlines cutting-edge strategies to combat tuberculosis (TB), highlighting novel ...

The use of adjuvants with immunopotentiating properties that can direct the immune responses to humoral ... pathogenic than the real pathogen; inactivated vaccines that are heat-inactivated ...

Results provide clinical demonstration of best-in-class immunogenicity achieved with an RNA-based platform and good tolerability RBI-4000's ...

Background Because inactivated trivalent influenza vaccines (TIVs ... B strain compared with TIV without interfering with immune responses to shared strains. Further studies are warranted to ...

Early results from a trial testing a 2009 H1N1 influenza vaccine in children look promising, according to the trial sponsor, the National Institute of Allergy and Infectious Diseases (NIAID), part ...

Vaccination is extremely crucial in reducing morbidity and mortality by protecting billions of people every year from infectious diseases. The key reason the adult population has grown significantly ...

Dairy farmers are being advised to focus on better vaccine strategies, not more doses, to improve efficacy and reduce calf ...

Our readers share their opinions on a variety of topics ...